pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    cabiralizumab
    cabiralizumab [INN]
    Pigmented Villonodular Synovitis Bristol-Myers Squibb Co
  • pre_registration
    cabozantinib
    cabozantinib
    Hepatocellular Carcinoma Lotus Pharmaceutical Co Ltd
  • Phase 3
    cadisegliatin
    cadisegliatin
    Type 1 Diabetes (Juvenile Diabetes)$VTVT vTv Therapeutics Inc.
  • Phase 2
← prev
page 162 of 231
next →
131
Pain89
Neurology1
cafelkibart
cafelkibart [INN]
Solid Tumor
LaNova Medicines Ltd
  • Phase 2
    caffeine
    caffeine
    Respiratory Depression (Hypoventilation) OYE Therapeutics Inc
  • Phase 3
    caficrestat
    caficrestat
    Cardiomyopathy Biossil Inc
  • Marketed
    calaspargase pegol
    Asparlas (calaspargase pegol)
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk… Servier Pharmaceuticals LLC
  • Marketed
    calcifediol ER
    Rayaldee (calcifediol)
    Secondary Hyperparathyroidism OPKO Pharmaceuticals LLC
  • Marketed
    calcitriol
    Calcitriol Sun Pharma (calcitriol)
    Renal Osteodystrophy Sun Pharmaceutical Industries Ltd
  • Marketed
    calcium acetate
    Calcium Acetate
    Hyperphosphatemia Nostrum Pharmaceuticals LLC
  • Marketed
    calfactant
    Infasurf (calfactant)
    Neonatal Respiratory Distress Syndrome Allergan USA Inc
  • Phase 1
    calotatug ginistinag
    calotatug ginistinag [INN]
    Colorectal Cancer$DAWN Day One Biopharmaceuticals, Inc.
  • Phase 2
    calpurbatug
    calpurbatug [INN]
    Prosthetic Joint infections Trellis Bioscience Inc
  • Phase 3
    camlipixant
    camlipixant
    Chronic Cough$GSK GSK plc
  • Phase 2
    camonsertib
    camonsertib
    Solid Tumor XenoTherapeutics Inc
  • Phase 2
    camupepimut
    camupepimut
    Colorectal Cancer$ELTX Elicio Therapeutics, Inc.
  • Preclinical
    candesartan
    candesartan
    Pancreatic Ductal Adenocarcinoma Hebrew University of Jerusalem
  • Marketed
    candesartan cilexetil
    Candesartan Cilexetil Par (candesartan cilexetil)
    Congestive Heart Failure (Heart Failure) Par Pharmaceutical Inc
  • Phase 2
    canerpaturev
    canerpaturev
    Metastatic Melanoma Takara Bio Inc
  • Marketed
    cangrelor
    Kengreal (cangrelor)
    Coronary Thrombosis Chiesi USA Inc
  • Marketed
    cannabidiol
    Epidiolex (cannabidiol)
    Infantile Spasm (West Syndrome)$JAZZ Jazz Pharmaceuticals plc
  • Preclinical
    cannabidiol + naltrexone ER
    cannabidiol + naltrexone
    Opium (Opioid) Addiction Aphios Corp
  • Phase 2
    cannabidivarin
    cannabidivarin
    Autism Spectrum Disorder (ASD)$JAZZ Jazz Pharmaceuticals plc
  • Marketed
    cantharidin
    Ycanth (cantharidin)
    Warts$VRCA Verrica Pharmaceuticals Inc.
  • Phase 2
    canvuparatide hydrochloride
    canvuparatide hydrochloride
    Hypoparathyroidism$MBX MBX Biosciences, Inc.
  • Marketed
    caplacizumab
    Cablivi (caplacizumab-yhdp)
    Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Genzyme Corp
  • Marketed
    capmatinib hydrochloride
    Tabrecta (capmatinib hydrochloride)
    Non-Small Cell Lung Cancer$NVS NOVARTIS AG
  • Marketed
    capsaicin
    Qutenza (capsaicin)
    Neuropathic Pain (Neuralgia) Grunenthal GmbH
  • Marketed
    captopril
    Captopril
    Congestive Heart Failure (Heart Failure) Innogenix Inc
  • Marketed
    carbinoxamine maleate
    Carbinoxamine Maleate
    Vasomotor Rhinitis Mission Pharmacal Co